Plaintiffs are eager to convert every corporate trauma into derivative claims, but they are anything but eager to confront the exacting standards for pleading and proving bad faith oversight under Caremark. Under Caremark and its progeny, directors are liable for failing to prevent corporate harm only under egregious circumstances in which they knowingly allow a corporation to violate or continue violating the law. Delaware courts routinely dismiss Caremark claims and have repeatedly emphasized that bad faith oversight is "possibly the most difficult theory in corporation law upon which a plaintiff might hope to win a judgment."